对ECMO患者的凝血实验室测试的解释
1Division of Medicine, Faculty of Medical Sciences, University College London, London, UK.
International journal of laboratory hematology
|May 15, 2024
概括
外体膜氧化 (ECMO) 需要专门的凝血测试,因为增加了出血和血栓形成的风险. 本次审查重点关注用于有效管理ECMO患者的基本实验室测试.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 临床病理学 临床病理学
背景情况:
- 身体外膜氧化 (ECMO) 的使用在全球范围内急剧增加,特别是在H1N1和SARS-CoV-2大流行期间,用于严重的呼吸衰竭.
- 由于肺损伤,电路相互作用,凝血病,炎症和抗凝血疗法,ECMO患者面临出血和血栓形成的风险增加.
研究的目的:
- 审查实验室凝血测试对于管理ECMO患者至关重要.
- 在与ECMO相关的独特挑战的背景下讨论这些测试的解释.
主要方法:
- 一个临床科学家的个人经验,在ECMO有20年的经验.
- 对ECMO中的凝血管理现有文献的综述.
主要成果:
- 为了患者的管理和结果的解释,ECMO需要特定的凝血测试.
- 专注于抗凝剂,测试频率和ECMO中的结果解释.
结论:
- 对ECMO患者的有效管理依赖于理解和应用适当的凝血实验室检测.
- ECMO对凝血的独特要求需要量身定制的诊断方法.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
01:09Coagulation
6.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.3K